Cardiovascular risk in type 2 diabetes patients

Cardiovascular risk in type 2 diabetes patients

Cardiovascular diseases remain leading cause of high mortality in diabetes patients. The article is focused on the influence of diabetes on cardiovascular risks. The prevalence presented, as the significance of the main and additional risk factors of cardiovascular diseases in the development of mac...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. D. Ostroumova, I. V. Goloborodova, V. М. Fomina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2018-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	diabetes mellitus cardiovascular risk arterial hypertension dyslipidemia obesity anti-diabetic therapy dapagliflozin
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/848
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of dapagliflozin on the structural and functional properties of arterial vessels in patients with type 2 diabetes mellitus in combination with obesity
by: О. А. Soloviuk, et al.
Published: (2020-12-01)

From Cardiovascular-Kidney-Metabolic Syndrome to Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Proposing an Expanded Framework
by: Nikolaos Theodorakis, et al.
Published: (2025-02-01)

Comparative study risk factors of cardiovascular disease among subjects with arterial hypertension in the population of the Ryazan region (study ESSE of the Russian Federation 2)
by: A. Glenza, et al.
Published: (2024-12-01)

Prevalence and Current Status of Cardiometabolic Risk Factors in Korean Adults Based on Fact Sheets 2024
by: Eun-Jung Rhee
Published: (2025-04-01)

The prevalence of major cardiovascular risk factors in a rural population of the Chui region of Kyrgyzstan: The results of an epidemiological study
by: Andrey G Polupanov, et al.
Published: (2020-08-01)

Type 2 diabetes: basic clinical and laboratory parameters and risk of cardiovascular death
by: O D Rymar, et al.
Published: (2020-05-01)

Eurasian clinical practice guidelines for dietary management of cardiovascular diseases (2024)
by: A. V. Starodubova, et al.
Published: (2024-11-01)

Recomendaciones preventivas vasculares. Actualización PAPPS 2024
by: Domingo Orozco-Beltrán, et al.
Published: (2024-11-01)

Association of prior tuberculosis with altered cardiometabolic profiles of people with HIV: A comparative cross-sectional study in Uganda
by: Joseph Baruch Baluku, et al.
Published: (2025-05-01)

Therapeutic education of patients with Type 2 diabetes mellitus and high cardiovascular risk
by: E. A. Palferova, et al.
Published: (2007-12-01)

ADVANCE Study: in patients with Type 2 diabetes mellitus, antihypertensive therapy decreases cardiovascular risk inde pendently of baseline blood pressure
by: I. E. Chazova
Published: (2008-04-01)

EFFECTS OF BIOLOGICAL AGE AND AGING RATES ON THE EXPRESSION OF RISK FACTORS IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS
by: V.D. Nemtsova
Published: (2019-12-01)

The Impact of Anti-Diabetics on Platelets Function and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: A Narrative Review
by: Muthanna Zaki, et al.
Published: (2025-01-01)

Reducing high risk of cardiovascular events in Type 2 diabetes mellitus: DIALOG Study results
by: I. E. Sapozhnikova, et al.
Published: (1970-01-01)

Cardiometabolic risk factors in patients with type 2 diabetes and sarcopenia
by: Yu. G. Samoilova, et al.
Published: (2024-02-01)

Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies
by: Nawfal Hasan Siam, et al.
Published: (2024-12-01)

Cardiovascular prevention 2022. Russian national guidelines
by: S. A. Boytsov, et al.
Published: (2023-06-01)

Comparative study of lipid profile among type 2 diabetics on treatment within Owo, metropolis, Nigeria.
by: Olaniyan, O.O., Adebayo T.O., Onyiba G.A., Atere A.D., Obot A.S., Ajayi A.A., Adedokun A.A., Shoyinka S.D., Yekeen S.B., and Abidoye O.J.
Published: (2024-01-01)

Association Between Long-term Statin Therapy and New-onset Diabetes in Cardiovascular Risk Patients in the UAE
by: Romona D. Govender, et al.
Published: (2024-11-01)

Joint associations of pre-diabetes, pre-hypertension, and pre-dyslipidemia with cardiovascular and metabolic disease progression
by: Cui Ma, et al.
Published: (2025-08-01)

When the body does not collaborate: pharmacological treatment of obesity
by: E. O. Taratukhin
Published: (2013-08-01)

The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus
by: T. Yu. Demidova, et al.
Published: (2020-09-01)

Influence of dapagliflozin on cardiovascular remodeling in hypertensive patients with accompanying type 2 diabetes
by: A. O. Bohun
Published: (2024-04-01)

Role of Adherence to Treatment in the Correction of the Risk of Cardiovascular Complications in Patients with Arterial Hypertension with Accompanying Diabetes Mellitus
by: O. Voloshyna, et al.
Published: (2024-09-01)

Factors associated with high cardiovascular risk in Putumayo
by: Jessica Paola Ruiz-Sandoval, et al.
Published: (2025-04-01)

Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
by: Olga Yuryevna Sukhareva, et al.
Published: (2016-01-01)

Exploring the effect of dapagliflozin on coronary inflammation in type 2 diabetes patients based on the coronary artery perivascular fat attenuation index
by: Xuehua Liu, et al.
Published: (2025-04-01)

The concept of fixed-dose combination drugs in primary and secondary prevention of cardiovascular disease. Position paper of the Russian Society of Cardiology, the Russian Society for the Prevention of Noncommunicable Diseases, the Russian Scientific Medical Society of Internal Medicine, the Russian Association of Endocrinologists, the Association of Clinical Pharmacologists, the Eurasian Association of Internal Medicine, the Russian Association of Gerontologists and Geriatricians
by: G. P. Arutyunov, et al.
Published: (2024-10-01)

Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice
by: M. M. Loukianov, et al.
Published: (2020-03-01)

Different obesity indicators and their correlation with hypertension, diabetes, and dyslipidemia in 35–74 years rural residents in Northwest China
by: Ting Yin, et al.
Published: (2025-06-01)

Exploring the bidirectional link between erectile dysfunction and 10-year cardiovascular risk in men with diabetes and hypertension
by: Hai Nguyen Ngoc Dang, et al.
Published: (2024-11-01)

Incident prescriptions for common cardiovascular medications: comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems
by: Candace D. McNaughton, et al.
Published: (2025-02-01)

Polysaccharides of Marine Algae in the Correction of Disorders Associated with Metabolic Syndrome
by: N. N. Besednova, et al.
Published: (2020-05-01)

Echocardiographic evaluation of cardiac function among male adolescents at high risk of coronary heart disease
by: Alaaeldin A. H. Mahmoud, et al.
Published: (2023-07-01)

Cardiovascular death risk reduction in type 2 diabetes patients with confirmed cardiovascular diseases
by: Е. V. Shlyakhto, et al.
Published: (2018-09-01)

Combination of dapagliflozin and pioglitazone lacks superiority against monotherapy in streptozotocin-induced nephropathy
by: Aneta Cinakova, et al.
Published: (2025-01-01)

H-NMR metabolomics identifies three distinct metabolic profiles differentially associated with cardiometabolic risk in patients with obesity in the Di@bet.es cohort
by: Enrique Ozcariz, et al.
Published: (2024-11-01)

SYSTEM FOR THE NEAREST CARDIOVASCULAR RISK ASSESSMENT IN SECOND TYPE DIABETES PATIENTS
by: N. V. Leonova, et al.
Published: (2016-04-01)

EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS
by: O. A. Koshel'skaya, et al.
Published: (2015-12-01)

Statins and diabetes mellitus: price of collaboration
by: Andrey Alexeevich Aleksandrov, et al.
Published: (2012-06-01)